Why These Analysts Cut Price Target On Teleflex
RBC Capital Markets says that Teleflex Incorporated (NYSE: TFX) delivered a Q1 beat and maintained 2022 guidance.
Morgan Stanley Maintains Equal-Weight on Teleflex, Lowers Price Target to $343
Morgan Stanley analyst Drew Ranieri maintains Teleflex (NYSE:TFX) with a Equal-Weight and lowers the price target from $378 to $343.
RBC Capital Maintains Outperform on Teleflex, Lowers Price Target to $390
RBC Capital maintains Teleflex (NYSE:TFX) with a Outperform and lowers the price target from $415 to $390.
Needham Maintains Buy on Teleflex, Lowers Price Target to $355
Needham analyst Mike Matson maintains Teleflex (NYSE:TFX) with a Buy and lowers the price target from $400 to $355.
Teleflex: Q1 Earnings Insights
Teleflex (NYSE:TFX) reported its Q1 earnings results on Thursday, April 28, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
How To Attend Teleflex Q1 2022 Earnings Conference Call
Teleflex (NYSE:TFX) will host a conference call at 08:00 AM ET on April 28, 2022, to discuss Q1 2022 earnings results.
Teleflex Announces Launch Of UroLift System In Japan For Treatment Of Benign Prostatic Hyperplasia
WAYNE, Pa., April 11, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, has announced the launch of the UroLift System in Japan for treating benign prostatic
Morgan Stanley Maintains Equal-Weight on Teleflex, Lowers Price Target to $378
Morgan Stanley maintains Teleflex (NYSE:TFX) with a Equal-Weight and lowers the price target from $383 to $378.
Raymond James Maintains Outperform on Teleflex, Raises Price Target to $380
Raymond James analyst Jayson Bedford maintains Teleflex (NYSE:TFX) with a Outperform and raises the price target from $370 to $380.